Investment to Fund Phase 1 Study in Renal Allograft Antibody-Mediated Rejection (AMR) in China SOUTH SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / December 11, 2025 / CASI Pharmaceuticals, Inc.
TipRanks on MSN
CASI Pharmaceuticals secures $20 million for renal AMR study
The latest announcement is out from CASI Pharmaceuticals ( (CASI) ).
New data link a common C3 gene variant to higher risk of chronic lung allograft dysfunction and antibody mediated rejection ...
Please provide your email address to receive an email when new articles are posted on . Acceptable liver transplant outcomes after immune checkpoint inhibitor therapy can be achieved. Age and length ...
BRISBANE, Calif.--(BUSINESS WIRE)-- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of ...
Transplantation of organs or tissues between genetically nonidentical individuals of the same species (and different species) is plagued by rejection and its associated problems. "Foreignness" is ...
In August, we reported on the decision by the Centers for Medicare & Medicaid Services (CMS) to not pursue a proposed Medicare policy that would have restricted coverage of a blood test used to ...
The FDA has approved Avance® (acellular nerve allograft-arwx) for the treatment of sensory nerve discontinuity.
Please provide your email address to receive an email when new articles are posted on . A matched case-control study found no association between corneal graft rejection and vaccination. These ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results